EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 2.0

CRP as a marker of inflammation: Mitigation of Ulcerative Colitis in rats by Mesalazine and Coenzyme Q10.

Hannah Pirzada, Zujaja Zaheer, Wardah Siddique, Binish Anwar, Haseeba Talat, Shazia Tabassum

Journal of Postgraduate Medical Institute · 31.03.2026 · 40 (1)

DOI: 10.54079/jpmi.40.1.3774 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Postgraduate Medical Institute, online erschienen am 31.03.2026. Verfasst von Hannah Pirzada und 5 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 2.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ulcerative colitis is a global health issue with no definitive treatment options available. Mesalazine is one of the first-line therapies available, and Coenzyme Q10 is a cellular component with anti-inflammatory, antioxidant, and cell-healing properties. This study evaluated the anti-inflammatory potential of mesalazine and Coenzyme Q10, alone and in combination, and C-reactive protein was assessed as a parameter of acute inflammation.

Methods

48 rats were divided into 6 groups. Ulcerative colitis was experimentally induced in rats and mesalazine and Coenzyme Q10 were given alone and in combination according to the grouping of animals. The kit method measured C-reactive protein levels in serum after 7 days. Results: the group treated with a combination of mesalazine and coenzyme Q10 showed a maximum reduction in C-reactive protein levels with only 12.5% with positive or >6mg/dl levels as compared to 100% with positive or >6mg/dl value in the disease-control group.

Conclusion

The study showed that the combination of mesalazine and coenzyme Q10 has synergistic potential in reducing inflammation in ulcerative colitis.

Zitieren

APA

Pirzada, H., Zaheer, Z., Siddique, W., Anwar, B., Talat, H., & Tabassum, S. (2026). CRP as a marker of inflammation: Mitigation of Ulcerative Colitis in rats by Mesalazine and Coenzyme Q10. Journal of Postgraduate Medical Institute, 40(1). https://doi.org/10.54079/jpmi.40.1.3774

Vancouver

Pirzada H, Zaheer Z, Siddique W, Anwar B, Talat H, Tabassum S. CRP as a marker of inflammation: Mitigation of Ulcerative Colitis in rats by Mesalazine and Coenzyme Q10. Journal of Postgraduate Medical Institute. 2026;40(1). doi:10.54079/jpmi.40.1.3774

BibTeX
@article{Pirzada2026,
  author = {Pirzada, Hannah and Zaheer, Zujaja and Siddique, Wardah and Anwar, Binish and Talat, Haseeba and Tabassum, Shazia},
  title = {CRP as a marker of inflammation: Mitigation of Ulcerative Colitis in rats by Mesalazine and Coenzyme Q10},
  journal = {Journal of Postgraduate Medical Institute},
  year = {2026},
  volume = {40},
  number = {1},
  doi = {10.54079/jpmi.40.1.3774}
}
Kostenlos starten →